Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury

The 2019 novel coronavirus (2019-nCoV) outbreak is a major challenge for clinicians. The clinical course of patients remains to be fully characterised, little data are available that describe the disease pathogenesis, and no pharmacological therapies of proven efficacy yet exist. Corticosteroids were widely used during the outbreaks of severe acute respiratory syndrome (SARS)-CoV1Stockman LJ Bellamy R Garner P SARS: systematic review of...